IRIS
FURLANUT, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.619
AS - Asia 2.823
EU - Europa 1.975
SA - Sud America 332
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 12.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.519
SG - Singapore 1.401
CN - Cina 611
UA - Ucraina 547
DE - Germania 308
HK - Hong Kong 288
BR - Brasile 277
IT - Italia 208
SE - Svezia 191
FI - Finlandia 170
RU - Federazione Russa 165
VN - Vietnam 140
FR - Francia 110
TR - Turchia 103
IE - Irlanda 101
IN - India 73
GB - Regno Unito 71
CA - Canada 66
KR - Corea 42
BD - Bangladesh 35
BE - Belgio 20
MX - Messico 18
ZA - Sudafrica 17
ES - Italia 16
IQ - Iraq 16
IR - Iran 15
AR - Argentina 14
SA - Arabia Saudita 14
JP - Giappone 13
NL - Olanda 13
CO - Colombia 11
CZ - Repubblica Ceca 11
PH - Filippine 9
EC - Ecuador 8
PK - Pakistan 8
PL - Polonia 8
CL - Cile 7
KZ - Kazakistan 6
MA - Marocco 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
EU - Europa 5
ID - Indonesia 5
IL - Israele 5
LT - Lituania 5
UZ - Uzbekistan 5
AL - Albania 3
AT - Austria 3
BB - Barbados 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TJ - Tagikistan 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SD - Sudan 1
Totale 12.795
Salva come PNG Salva come JPEG
Città #
Fairfield 879
Singapore 695
Ann Arbor 674
Woodbridge 647
Ashburn 622
Chandler 490
Houston 437
Seattle 352
Wilmington 351
Jacksonville 347
Beijing 306
Hong Kong 288
Cambridge 284
San Jose 258
Dearborn 212
Boardman 130
Dublin 100
Princeton 98
Izmir 89
Lauterbourg 88
New York 87
Udine 87
Los Angeles 78
Des Moines 58
San Diego 52
Munich 49
Buffalo 45
Ho Chi Minh City 41
Dallas 39
Hanoi 37
Santa Clara 33
The Dalles 33
Ottawa 31
Seoul 31
Orem 30
Hefei 29
Redondo Beach 27
Helsinki 25
São Paulo 24
Ogden 23
Mumbai 21
Brussels 20
Nanjing 19
Brooklyn 17
San Mateo 15
Turku 15
Kunming 14
Denver 13
Frankfurt am Main 13
Jinan 12
San Francisco 12
Tokyo 12
Atlanta 11
Falls Church 11
Guangzhou 11
Leawood 11
Manchester 11
Montreal 11
Shanghai 11
Augusta 10
Boston 10
Dhaka 10
Johannesburg 10
Norwalk 10
Rome 10
London 9
Mexico City 9
Monmouth Junction 9
Poplar 9
Trieste 9
Belo Horizonte 8
Brno 8
Düsseldorf 8
Nanchang 8
Naples 8
Phoenix 8
Warsaw 8
Brasília 7
Chennai 7
Chicago 7
Da Nang 7
Toronto 7
Winnipeg 7
Amsterdam 6
Ankara 6
Hebei 6
Lahore 6
Milan 6
Moscow 6
Rio de Janeiro 6
Baku 5
Bologna 5
Changsha 5
Council Bluffs 5
Grafing 5
Miami 5
Padova 5
Riyadh 5
Salvador 5
Wenzhou 5
Totale 8.761
Salva come PNG Salva come JPEG
Nome #
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 208
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 207
Chlorpromazine disposition in relation to age in children 194
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 193
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 191
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 191
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 183
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 176
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 174
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 170
Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation 166
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 165
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 164
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 163
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 162
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 161
Determination of tamoxifen and its metabolites in the endometrial tissue of long term treated women 161
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 160
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 160
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 159
Calculating percentage prediction error: a user's note 159
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 158
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 158
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 157
Side effects of imipramine therapy in enuretic children. 156
Chronopharmacokinetics of ciclosporin and tacrolimus 155
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 154
Blood concentrations and clinical effect of cyclosporin in psoriasis 152
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 151
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 150
Effect of fluctuations of blood cyclosporine concentrations on renal function. 149
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 148
Pharmacology of ifosfamide 148
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 148
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 146
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 145
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 145
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 144
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 143
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 143
A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients 142
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 142
Fluoxetine disposition in patients suffering from chronic hepatitis C treated with interferon alpha 141
Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation 141
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 141
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 140
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 139
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 139
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 138
Imipramine pharmacokinetics in depressed geriatric patients 137
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 137
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 137
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 136
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 135
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 133
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients 133
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy 130
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 126
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient 125
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 124
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients 122
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis 122
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 120
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose 119
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 119
MEGX disposition in critically-ill trauma patients: Subsequent assessments during the first week following trauma 117
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 116
Isoniazid and its hydrazine metabolite in patients with tuberculosis 116
Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women 114
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 114
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy 114
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 110
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 109
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 108
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 108
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 106
Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers 104
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration 103
Un caso di encefalite da Mycoplasma pneumoniae trattato con levofloxacina 103
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 100
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 99
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 97
Farmacologia generale e clinica per le lauree sanitarie - III Edizione - Ed. Piccin 97
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 97
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 96
Oral and intravenous disposition of cyclosporine in psoriatic patients. 95
Pharmacokinetic aspects of levofloxacin 500 mg once-daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections 93
Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients? 91
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 91
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages 90
Farmacologia - Principi e applicazioni 88
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 87
Farmacologia generale e clinica per le lauree sanitarie - II edizione 79
Personalization of antimicrobial dosing regimens: Indicators of performance 75
Farmacologia generale e clinica per le lauree triennali 74
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 74
Variability in the metabolism of levodopa and clinical implications 73
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients 63
Totale 13.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 0 0 0 0 181 66
2021/2022941 40 68 47 89 48 50 43 42 15 154 209 136
2022/20231.021 112 90 18 127 132 276 0 74 130 13 20 29
2023/2024319 55 23 7 5 60 72 6 19 36 6 2 28
2024/20251.656 40 110 104 45 73 87 89 107 139 117 312 433
2025/20263.105 295 356 236 276 522 269 467 91 230 274 89 0
Totale 13.036